FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Actavis Laboratories, FL Ramipril Capsules Recall

Ramipril Capsules, USP, 1

Actavis Laboratories, FL, Inc. · Davie, FL

Risk level
Class III
Reported by FDA
Nov 9, 2016
Recall ID
D-0118-2017
Check your lot numberHow we source this data

Summary

Actavis Laboratories, FL recalled Ramipril Capsules starting Aug 30, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0118-2017 on Nov 9, 2016. Reason: Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17. Status: Ongoing.

Why it was recalled

Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

Product description

Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.

Lot numbers, UPCs & expiration codes

Lot #: 1136091A, Incorrectly Labeled Exp: 03/18

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0118-2017
Classification
Class III
Status
Ongoing
Recall initiated
Aug 30, 2016
FDA report date
Nov 9, 2016
Quantity
15,984 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Laboratories, FL, Inc.

Original FDA data

Every field from FDA enforcement report D-0118-2017, exactly as published.

Show all FDA fields
City
Davie
State
FL
Status
Ongoing
Country
United States
Event ID
75042
Address
4955 Orange Dr
Code information
Lot #: 1136091A, Incorrectly Labeled Exp: 03/18
Postal code
33314-3902
Report date
Nov 9, 2016
Product type
Drugs
Recall number
D-0118-2017
Classification
Class III
Recalling firm
Actavis Laboratories, FL, Inc.
Product quantity
15,984 bottles
Reason for recall
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Aug 30, 2016
Initial firm notification
Letter
Center classification date
Nov 1, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0118-2017, published Nov 9, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls